Structure-activity relationship studies of CNS agents - Part 24:3 New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135)

Pharmazie

Volumn 51, Issue 2, 1996, Pages 72-76

  Boksa, J ^a   Kłodzińska, Aleksandra ^a   Charakchieva Minol, Sijka ^a   Chojnacka Wójcik, Ewa ^a   Mokrosz, J L ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA 1 ADRENERGIC RECEPTOR; CENTRAL NERVOUS SYSTEM AGENTS; KETANSERIN; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; PIPERAZINE DERIVATIVE; PRAZOSIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOMER; HIPPOCAMPUS; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; PIPERAZINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029986706     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cliffe, I. A.; Brightwell, C. I.; Fletcher, A.; Forster, E. A.; Mansell, H. L.; Reilly, Y.; Routledge, C.: White, A. C.: J. Med. Chem. 36, 1509 (1993)
2. Fletcher, A., Bill, D. J.; Bill, S. J.; Cliffe, I. A.; Dover, G. M.; Forster, E. A.; Haskins, J. T.; Jones, D.; Mansell, H. L.; Reilly, Y.; Eur. J. Pharmacol. 237, 283 (1993)
3. Przegaliński, E., Filip, M.; Budziszewska, B.; Chojnacka-Wójcik, E.: Pol. J. Pharmacol. 46, 21 (1994)
4. Zhuang, Z.-P.; Kung, M.-P.; Kung, H. F.: J. Med. Chem. 37, 1406 (1994)
5. Fletcher, A.; Bill, D. J.; Cliffe, I. A.; Forster, E. A.; Jones, D.; Reilly, Y., Br. J. Pharmacol. 112 (proceed. Suppl.), 91P (1994)
6. Mokrosz, J. L.; Paluchowska, M. H ; Chojnacka-Wójcik, E.; Filip, M.; Charakchieva-Minol, S.; Dereń-Wesołek, A.; Mokrosz, M. J.: J. Med. Chem. 37, 2754 (1994)
7. Mokrosz, M. J ; Chojnacka-Wójcik, E.; Tatarczyńska, E.; Kłodzińska, A.; Filip, M.; Boksa, J., Charakchieva-Minol, S.; Mokrosz, J. L.: Med. Chem. Res 4, 161 (1994)
8. Mokrosz, J L., Kiodzińska, A., Boksa, J.; Bojarski, A. J., Duszyńska, B ; Chojnacka-Wójcik, E.: Arch. Pharm. (Weinheim) 328, 381 (1995)
9. Gozlan, H.; Thibault, S.; Laporte, A.-M.; Lima, L.; Hamon, M.: Eur. J. Pharmacol., Mol. Pharmacol. Sect. 288, 173 (1995)
10. Raghupathi, R. K.; Rydelek-Fitzgerald, L.; Teitler, M.; Glennon, R. A : J. Med. Chem. 34, 2633 (1991)
11. El-Bermawy, M.; Raghupathi, R ; Ingher, S. P.; Teitler, M.; Maayani, S.: Glennon. R. A.: Med. Chem. Res. 2, 88 (1992)
12. Routledge, C ; Gurling, J , Wright, I. K.; Dourish, C. T.: Eur. J. Pharmacol. 239, 195 (1993)
13. Critchley, D. J. P.; Middlefell, V. C.; Liddle, C. W.; Foden, N. D.; Dourish C. T.: Eur. J. Pharmacol. 254, 133 (1994)
14. Rhodes, K. F ; Dover, G.; Lattimer, N.: Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 225 (1993)
15. Hartley, J. E.; Fletcher, A.: Eur J. Pharmacol. 252, 329 (1994)
16. Berendsen, H. H. G.; Jenck, F.; Broekkamp, C. L. E.: Pharmacol. Biochem. Behav. 33, 821 (1989)
17. Berendsen, H. H. G.; Broekkamp, C. L. E.; Van Dełft. A. M L.: Eur J. Pharmacol. 187, 97 (1990)
18. Berendsen, H H. G.; Broekkamp, C. L. E., Van Delft, A. M. L.: Behav. Neural Biol. 55, 214 (1991)
19. Berendsen, H. H. G., Bourgondien, F. G. H., Broekkamp, C. L. E.: Eur. J. Pharmacol. 263, 315 (1994)
20. Bojarski, A J.; Cegła, M: T.; Charakchieva-Minol, S.; Mokrosz, M. J.; Maćkowiak, M.; Misztal, S.; Mokrosz, J. K.: Pharmazie 48, 289 (1993)
21. Maj, J.; Klimek, V.; Nowak, G.: Eur. J. Pharmacol. 119, 113 (1985)